Fortress Biotech Inc.

12/07/2021 | Press release | Distributed by Public on 12/07/2021 07:00

Fortress Biotech, Cyprium Therapeutics and Sentynl Therapeutics Announce the Initiation of Rolling Submission of a New Drug Application for CUTX-101, Copper Histidinate, for[...]